Triple H therapy for subarachnoid hemorrhage consists of all except:-
**Core Concept**
Triple H therapy is a treatment approach for subarachnoid hemorrhage (SAH) that aims to reduce intracranial pressure (ICP) and improve cerebral perfusion pressure (CPP). This therapy involves the combination of three main interventions: Hypertension, Hemodilution, and Hypervolemia.
**Why the Correct Answer is Right**
The correct components of Triple H therapy are Hypertension, Hemodilution, and Hypervolemia. Hypertension is achieved through the administration of vasopressors, such as phenylephrine or norepinephrine, to increase blood pressure and CPP. Hemodilution involves the administration of fluids, such as lactated Ringer's solution, to dilute blood viscosity and improve microcirculatory blood flow. Hypervolemia is achieved through the administration of colloids or crystalloids to increase blood volume and CPP. This combination of interventions helps to reduce ICP, improve CPP, and prevent delayed cerebral ischemia.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is a distractor, and the actual answer will be revealed below.
* **Option B:** This option is not a component of Triple H therapy.
* **Option C:** This option is not a component of Triple H therapy.
* **Option D:** This option is not a component of Triple H therapy.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that the goal of Triple H therapy is to improve CPP and reduce ICP, which can help prevent delayed cerebral ischemia and improve outcomes in patients with SAH.
**Correct Answer: B, C, D. These options are not components of Triple H therapy.**